Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Principal Investigator
Name
Daehee Kang
Institution
NCI, DCEG, OEEB
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
2006-0005
Initial CDAS Request Approval
Jul 1, 2006
Title
NOS Genetics
Summary
This study is conducted to evaluate the potential role of selected single nucleotide polymorphisms (SNPs) of NOS2 and NOS3 with large number of subjects in prostate cancer development with a nested case-control design in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial.
Aims

To study the association between selected genetic polymorphisms of NOS and prostate cancer, especially advanced prostate cancer To evaluate the interactive effects of genetic polymorphisms of NOS and environmental exposure on prostate cancer development.

Collaborators

Ed Glemann (Georgetown University)
Richard Hayes (Division of Cancer Epidemiology and Genetics)
Wen-Yi Huang (Division of Cancer Epidemiology and Genetics)

Related Publications